» Articles » PMID: 31242091

Extracorporeal Shock Wave Therapy to Treat Neurogenic Heterotopic Ossification in a Patient with Spinal Cord Injury: A Case Report

Overview
Date 2019 Jun 27
PMID 31242091
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

To evaluate the efficacy and safety of treatment for neurogenic heterotopic ossification (NHO) using extracorporeal shock wave therapy (ESWT) in persons with spinal cord injury (SCI). Single case report. Department of Physical Medicine and Rehabilitation, Veterans Health Service Medical Center. A 55-year-old male with cervical SCI, who developed painful NHO around the right hip joint. Ultrasound-guided ESWT that used 4,000 shocks at the rate of 3 Hz and the energy flux density between 0.056 and 0.068 mJ/mm was applied to the NHO region a total of 7 times, weekly. We assessed the treatment outcomes using a visual analog scale (VAS) score, wheelchair sitting time and size of NHO.: After 7 weeks of ESWT treatment, his pain reduced from a VAS score of 7-8 to 3 and his wheelchair sitting time increased. However, there was no significant change of size of NHO. The application of ESWT could be a possible alternative to other treatments for NHO in persons with SCI.: 2019-03-003.

Citing Articles

HETEROTOPIC OSSIFICATION AFTER SPINAL CORD INJURY: PREVENTION AND TREATMENT - A SISTEMATIC REVIEW.

Yukie Nakano Schincariol C, Echauri E, Silvestre O, Cliquet A Acta Ortop Bras. 2023; 31(3):e267451.

PMID: 37469500 PMC: 10353873. DOI: 10.1590/1413-785220233103e267451.


Neurogenic Heterotopic Ossification of the Hip after Brain Injury. Function Recovery Preserving Hip Joint: A Case Report.

Iorio R, Viglietta E, Massafra C, Ferretti A J Orthop Case Rep. 2022; 11(6):97-101.

PMID: 35437503 PMC: 9009476. DOI: 10.13107/jocr.2021.v11.i06.2276.


Extracorporeal shockwave therapy in spinal cord injury, early to advance to clinical trials? A systematic review and meta-analysis on animal studies.

Alavi S, Madani Neishaboori A, Yousefifard M Neuroradiol J. 2021; 34(6):552-561.

PMID: 34224252 PMC: 8649182. DOI: 10.1177/19714009211026899.


Enhanced Spinal Therapy: Extracorporeal Shock Wave Therapy for the Spine.

Fiani B, Davati C, Griepp D, Lee J, Pennington E, Moawad C Cureus. 2020; 12(10):e11200.

PMID: 33269131 PMC: 7704023. DOI: 10.7759/cureus.11200.


Post-stroke bilateral heterotopic ossification: An acute problem with long-lasting consequences.

Ozen S, Boluk Senlikci H, Yemisci O Jt Dis Relat Surg. 2020; 31(2):386-389.

PMID: 32584742 PMC: 7489164. DOI: 10.5606/ehc.2020.72081.


References
1.
Banovac K . The effect of etidronate on late development of heterotopic ossification after spinal cord injury. J Spinal Cord Med. 2000; 23(1):40-4. DOI: 10.1080/10790268.2000.11753507. View

2.
Reznik J, Gordon S, Barker R, Keren O, Arama Y, Galea M . Extracorporeal Shock Wave Therapy (ESWT) as a treatment for recurrent Neurogenic Heterotopic Ossification (NHO). Brain Inj. 2013; 27(2):242-7. DOI: 10.3109/02699052.2012.729293. View

3.
Teasell R, Mehta S, Aubut J, Ashe M, Sequeira K, Macaluso S . A systematic review of the therapeutic interventions for heterotopic ossification after spinal cord injury. Spinal Cord. 2010; 48(7):512-21. PMC: 3218076. DOI: 10.1038/sc.2009.175. View

4.
Chang J, Li C, Liao H, Wang C, Wang G, Ho M . Anti-inflammatory drugs suppress proliferation and induce apoptosis through altering expressions of cell cycle regulators and pro-apoptotic factors in cultured human osteoblasts. Toxicology. 2009; 258(2-3):148-56. DOI: 10.1016/j.tox.2009.01.016. View

5.
Chao S, Joyce M, Suh J . Treatment of heterotopic ossification. Orthopedics. 2007; 30(6):457-64. DOI: 10.3928/01477447-20070601-18. View